ONO Pharmaceutical to acquire Deciphera Pharmaceuticals in $2.4bn deal

ONO Pharmaceutical, Co., Ltd., has entered into a definitive agreement to acquire all outstanding shares of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), for $25.60 per share ... Read More